SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001558370-21-011669
Filing Date
2021-08-13
Accepted
2021-08-13 16:02:55
Documents
56
Period of Report
2021-06-30

Document Format Files

Seq Description Document Type Size
1 10-Q tmb-20210630x10q.htm   iXBRL 10-Q 1522701
2 EX-31.1 tmb-20210630xex31d1.htm EX-31.1 18445
3 EX-31.2 tmb-20210630xex31d2.htm EX-31.2 18503
4 EX-32.1 tmb-20210630xex32d1.htm EX-32.1 8289
5 EX-32.2 tmb-20210630xex32d2.htm EX-32.2 8777
  Complete submission text file 0001558370-21-011669.txt   5898606

Data Files

Seq Description Document Type Size
6 EX-101.SCH tmb-20210630.xsd EX-101.SCH 40167
7 EX-101.CAL tmb-20210630_cal.xml EX-101.CAL 43924
8 EX-101.DEF tmb-20210630_def.xml EX-101.DEF 138129
9 EX-101.LAB tmb-20210630_lab.xml EX-101.LAB 339273
10 EX-101.PRE tmb-20210630_pre.xml EX-101.PRE 263548
11 EXTRACTED XBRL INSTANCE DOCUMENT tmb-20210630x10q_htm.xml XML 999184
Mailing Address 29 EMMONS DRIVE SUITE B-10 PRINCETON NJ 08540
Business Address 29 EMMONS DRIVE SUITE B-10 PRINCETON NJ 08540 609-538-8200
SOLIGENIX, INC. (Filer) CIK: 0000812796 (see all company filings)

IRS No.: 411505029 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-14778 | Film No.: 211172025
SIC: 2834 Pharmaceutical Preparations